Cardiometabolic Risk Profile in Acute Coronary Syndrome Patients

Cardiometabolic syndrome (CMS), also known as metabolic syndrome X or insulin resistance syndrome is a cluster of metabolic abnormalities including central obesity associated with hyperglycemia, dyslipidemia or hypertension. Each component of CMS is individually associated with an increased risk of coronary events and has a different impact on outcomes and long-term mortality.